Literature DB >> 26452490

[The value of supracricoid partial laryngectomy in moderately advanced laryngeal cancer (T3-T4a)].

U Schroeder1, B Wollenberg2, K L Bruchhage2.   

Abstract

BACKGROUND: Transoral laser microsurgery (TLM) is the method of choice for partial laryngectomy in Germany. In advanced stages, chemoradiotherapy is increasingly indicated for organ preservation.
OBJECTIVE: This report considers the indications for and outcomes of supracricoid partial laryngectomy (SPL), also known as crico-hyoido-(epiglotto)-pexy, as an option for surgical organ preservation in moderately advanced laryngeal cancer (T3-T4a), in the well-defined gap between TLM and chemoradiotherapy protocols in Germany.
METHODS: Retrospective evaluation of functional and oncological outcomes of all SPLs conducted between 2008 and 2014. During this period, 17 SPLs with resection of rpT2 (n = 2), (r)pT3 (n = 11), and (r)pT4a (n = 4) were performed with resection of one arytenoid. Mean age was 58 years (range 47-75 years). In 5 patients, SPL was for a first or second local recurrence after TLM or open partial laryngectomy. Adjuvant radiotherapy was received by 7 patients staged pT4a or pN+.
RESULTS: Salvage laryngectomy with adjuvant radiotherapy was required by 2 patients. The remaining patients (n = 15) had a mean tumor-free follow-up of 4 years with a functional intact larynx: these patients can eat and drink, have a closed tracheotomy, and a good voice. After 3 years tumor-free follow-up with a functional intact larynx, 2 patients died due to cardiac comorbidity at the age of 76 years. DISCUSSION: SPL is a rare but valuable option for surgical larynx preservation in stage pT3-4a laryngeal cancer.

Entities:  

Keywords:  Cricoid cartilage; Laryngeal cancer; Larynx preservation; Partial laryngectomy; Surgery

Mesh:

Year:  2015        PMID: 26452490     DOI: 10.1007/s00106-015-0071-0

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  27 in total

Review 1.  [Current value of open-preservation surgery with special emphasis given to the supracricoid laryngectomy].

Authors:  U Schröder
Journal:  Laryngorhinootologie       Date:  2007-07       Impact factor: 1.057

2.  Transoral laser microsurgery in treatment of pT2 and pT3 glottic laryngeal squamous cell carcinoma - results of 391 patients.

Authors:  Martin Canis; Alexios Martin; Friedrich Ihler; Hendrik A Wolff; Martina Kron; Christoph Matthias; Wolfgang Steiner
Journal:  Head Neck       Date:  2013-09-02       Impact factor: 3.147

3.  Cricohyoidoepiglottopexy for glottic carcinoma with fixation or impaired motion of the true vocal cord: 5-year oncologic results with 112 patients.

Authors:  D Chevalier; O Laccourreye; D Brasnu; H Laccourreye; J J Piquet
Journal:  Ann Otol Rhinol Laryngol       Date:  1997-05       Impact factor: 1.547

4.  Glottic and supraglottic pT3 squamous cell carcinoma: outcomes with transoral laser microsurgery.

Authors:  Dimitrios Pantazis; Georgia Liapi; Dimitrios Kostarelos; Georgios Kyriazis; Theodoros-Leonidas Pantazis; Maria Riga
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-29       Impact factor: 2.503

5.  [Results of transoral laser resection in T1-2 oropharyngeal, hypopharyngeal and laryngeal carcinomas].

Authors:  H Iro; K Mantsopoulos; J Zenk; F Waldfahrer; G Psychogios
Journal:  Laryngorhinootologie       Date:  2011-08-17       Impact factor: 1.057

6.  Local control after supracricoid partial laryngectomy for "advanced" endolaryngeal squamous cell carcinoma classified as T3.

Authors:  Xavier Dufour; Stéphane Hans; Erwan De Mones; Daniel Brasnu; Madeleine Ménard; Ollivier Laccourreye
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-09

7.  [Cricohyoidopexy (CHP) and Cricohyoidoepiglottopexy (CHEP). Indication, complications, functional und oncological results].

Authors:  U Schröder; M Jungehülsing; J P Klussmann; H E Eckel
Journal:  HNO       Date:  2003-01       Impact factor: 1.284

8.  Neo-adjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidopexy for advanced endolaryngeal carcinoma classified as T3-T4: 5-year oncologic results.

Authors:  O Laccourreye; D Brasnu; B Biacabe; S Hans; S Seckin; G Weinstein
Journal:  Head Neck       Date:  1998-10       Impact factor: 3.147

Review 9.  Swing of the pendulum: optimizing functional outcomes in larynx cancer.

Authors:  F Christopher Holsinger
Journal:  Curr Oncol Rep       Date:  2008-03       Impact factor: 5.075

10.  Organ preservation in T4a laryngeal cancer: is transoral laser microsurgery an option?

Authors:  Martin Canis; Friedrich Ihler; Alexios Martin; Hendrik A Wolff; Christoph Matthias; Wolfgang Steiner
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-14       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.